Interesting question" As far as I am aware (I am clinical not research), the answer is yes. Many examples in oncology, and the whole idea of re-purposing drugs, in essence, utilises this pathway. Might well be something neuren are thinking of!
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.11%
!
$13.25

Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-151
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.25 |
Change
0.400(3.11%) |
Mkt cap ! $1.652B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.204M | 320.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 283 | $13.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.25 | 115 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 313 | 13.230 |
6 | 550 | 13.220 |
16 | 3126 | 13.210 |
8 | 1680 | 13.200 |
4 | 1270 | 13.190 |
Price($) | Vol. | No. |
---|---|---|
13.250 | 115 | 5 |
13.260 | 867 | 11 |
13.270 | 1648 | 10 |
13.280 | 1495 | 8 |
13.290 | 2261 | 6 |
Last trade - 12.09pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online